1. Tsuang, Ming T. 美国 University of California, San Diego 1994美国医学院院士 Linking enlarged choroid plexus with plasma analyte and structural phenotypes in clinical high risk ..
2. 贺林 中国 上海交通大学 中国科学院院士 Methylome-wide association study of different responses to risperidone in schizophrenia
3. Bruce R,Rosen 美国 Harvard University 2010美国医学院院士 The pandemic brain: Neuroinflammation in non-infected individuals during the COVID-19 pandemic
4. Jeste, Dilip V. 美国 University of California, San Diego 2006美国医学院院士 Associations between inflammatory marker profiles and neurocognitive functioning in people with schi..
5. Murray, Robin M. 英国 University of London 2003美国医学院院士 Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a..
6. Murray, Robin M. 英国 University of London 2003美国医学院院士 Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-resp..
7. Gur, Raquel E. 美国 University of Pennsylvania Medical Center 2001美国医学院院士 Disruption of the blood-brain barrier in 22q11.2 deletion syndrome
8. Lieberman, Jeffrey A. 美国 Columbia University College of Physicians and Surgeons 2001美国医学院院士 Advancing study of cognitive impairments for antipsychotic-na?ve psychosis comparing high -income ve..
9. Kalin, Ned H. 美国 University of Wisconsin School of Medicine and Pub 2015美国医学院院士 Gaining Ground on Schizophrenia: Conceptualizing How to Use Neuroimaging and Genomics in Its Diagnos..
10. Jeste, Dilip V. 美国 University of California, San Diego 2006美国医学院院士 Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptom..
11. Murray, Robin M. 英国 University of London 2003美国医学院院士 Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with ..
12. Weinberger, Daniel R. 美国 Lieber Institute for Brain Development 1999美国医学院院士 Attacking Heterogeneity in Schizophrenia by Deriving Clinical Subgroups From Widely Available Sympto..
13. Berman, Karen F. 美国 National Institutes of Health 2016美国医学院院士 Attacking Heterogeneity in Schizophrenia by Deriving Clinical Subgroups From Widely Available Sympto..
14. Kraemer, Helena Chmura 美国 Stanford University 2003美国医学院院士 Elevated plasma F2-isoprostane levels in schizophrenia
15. Jeste, Dilip V. 美国 University of California, San Diego 2006美国医学院院士 Elevated plasma F2-isoprostane levels in schizophrenia
16. Tamminga, Carol A. 美国 The University of Texas Southwestern Medical Center 1998美国医学院院士 Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives
17. Celso,Arango 西班牙 University of COMPLUTENSE 2023美国医学院院士 Predictors of Functional and Clinical Outcome in Early-Onset First-Episode Psychosis: The Child and ..
18. Celso,Arango 西班牙 University of COMPLUTENSE 2023美国医学院院士 Inflammation in schizophrenia: A question of balance
19. 李校堃 中国 温州医科大学 中国工程院院士 Association of the dopamine -hydroxylase 19bp insertion/deletion polymorphism with positive symptoms..
20. Weinberger, Daniel R. 美国 Lieber Institute for Brain Development 1999美国医学院院士 The Interleukin 3 Gene (IL3) Contributes to Human Brain Volume Variation by Regulating Proliferation..